Chinese Researchers Developing Drug To Counter Vaccine Injuries…How Convenient
After releasing the CCP virus on the world, killing millions, Chinese researchers are now developing a drug to treat the horrific effects on the human body of artificial spike proteins created by the ‘vaccines’, which are really not ‘vaccines’ at all but experimental gene mutation technology. In the United States, over 13,000 deaths (likely highly under-reported) have been logged, along with 500,000 serious adverse events to the vaccines. In Europe, which has a stronger reporting system, close to 20,000 deaths have been reported and approximately 2 million serious adverse reactions.
The ‘vaccines’ are clearly not safe. Now it looks like Chinese researchers want to make money off this fact. How convenient.
In a recent study, we reported that certain anti-spike antibodies of COVID-19 and SARS-CoV viruses can have a pathogenic effect through binding to sick lung epithelium cells and misleading immune responses to attack self-cells. We termed this new pathogenic mechanism “Antibody Dependent Auto-Attack” (ADAA). This study explores a drug candidate for prevention and treatment of such ADAA-based diseases, wrote Huiru Wang, Xiancong Wu, Yuekai Zhang, Qiuchi Chen, Lin Dai, Yuxing Chen, Xiaoling Liu in the report titled ‘A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccines’ which was printed in bioRxiv, advertised as the ‘Preprint Server for Biology’.
Compared to existing antiviral drugs, the formulation has a unique MOA of targeting receptors, broad spectrum of indications, excellent safety profile, resistance to mutations, and can be easily produced.
Help Us Fight Censorship
Big tech is silencing Republican voices but we are here to help keep you informed by hunting down real news and sharing it with you. If you like the content we share please feel free to subscribe to our newsletter, this article was shared from CDMedia